NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Foresite Capital Management’

21 May 2015

Vivo Capital, Venrock help gene therapy business Regenxbio to weighty $70.5m Series D

microscope pic Gene therapy-focused biotech business Regenxbio has closed a hefty $70.5m Series D financing round thanks to investment from firms including Vivo Capital and Venrock.

14 January 2015

Foresite leads $55.5m Series B round in 10X Genomics

it health Health-focused Foresite Capital Management has led a hefty $55.5m Series B financing round in genomics platform provider 10X Genomics.

13 March 2014

OrbiMed helps Sage Therapeutics raise $38m

medical monitor Healthcare-focused investment firm OrbiMed Advisors participated in a $38m Series C round for biopharmaceutical company Sage Therapeutics.

3 July 2013

Foresite Capital leads $30m Series C for biotech group Sequenta

cancer band pink_sq Healthcare focused firm Foresite Capital Management has led a $20m Series C round for biotechnology company Sequenta.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015